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ABSTRACT
Background and the purpose of the study: The most prominent nanoparticles for medical uses are 
nanosilver particles which are famous for their high anti-microbial activity. Silver ion has been 
known as a metal ion that exhibit anti-mold, anti-microbial and anti-algal properties for a long 
time. In particular, it is widely used as silver nitrate aqueous solution which has disinfecting and 
sterilizing actions. The purpose of this study was to evaluate the antimicrobial activity as well as 
physical properties of the silver nanoparticles prepared by chemical reduction method.
Methods: Silver nanoparticles (NPs) were prepared by reduction of silver nitrate in the presence 
of a reducing agent and also poly [N-vinylpyrolidone] (PVP) as a stabilizer. Two kinds of NPs 
were synthesized by ethylene glycol (EG) and glucose as reducing agent. The nanostructure and 
particle size of silver NPs were confirmed by scanning electron microscopy (SEM) and laser 
particle analyzer (LPA). The formations of the silver NPs were monitored using ultraviolet-
visible spectroscopy. The anti-bacterial activity of silver NPs were assessed by determination 
of their minimum inhibitory concentrations (MIC) against the Gram positive (Staphylococcus 
aureus  and  Staphylococcus  epidermidis)  as  well  as  Gram-negative  (Escherichia  coli  and 
Pseudomonas aeruginosa) bacteria.
Results and Conclusion: The silver nanoparticles were spherical with particle size between 10 
to 250 nm. Analysis of the theoretical (Mie light scattering theory) and experimental results 
showed that the silver NPs in colloidal solution had a diameter of approximately 50 nm. 
Both colloidal silver NPs showed high anti-bacterial activity against Gram positive and Gram 
negative bacteria. Glucose nanosilver colloids showed a shorter killing time against most of the 
tested bacteria which could be due to their nanostructures and uniform size distribution patterns. 
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INTRODUCTION
The  use  of  silver  and  other  metal  ions  for  their 
sustained  anti-fungal,  anti-bacterial  and  anti-viral 
effects have been practiced for a long time. Such 
effects  are  generally  referred  as  oligodynamic 
action. Recent studies have focused on the synthesis 
of  homogenous  silver  nanoparticles  (NPs)  and 
evaluation  of  their  antimicrobial  activities  (1,  2). 
Silver ion has been known to be effective against 
a broad range of microorganisms. Silver NPs with 
higher surface to volume ratio compared to common 
metallic  silver  have  shown  better  antimicrobial 
activity. Due to unique biological properties of silver 
NPs  such  as  biocompatibility  and  anti-bacterial 
affinity they have been applied for various medical 
purposes such as implants, catheters, and healing of 
wounds (3, 4). 
Synthesis  of  silver  NPs  has  been  of  considerable 
interest  during  the  past  decades  (5). A  variety  of 
methods have been reported for synthesis of metallic 
NPs.  These  include  thermal  decomposition,  laser 
ablation,  microwave  irradiation,  sonochemical, 
reverse  micelles,  salt  reduction,  radiolysis, 
solvothermal  and  electrochemical  synthesize  (6). 
However controlling the particle size and production 
of particles by an industrial scale is an important 
task of all methods.  Chemical reduction of metal 
salts using various reducing agents in the presence 
of stabilizer is currently of interest for preparation 
of metal NPs (7, 8). However, it hitherto is difficult 
to realize a composition which provides a suitable 
oligodynamic  antimicrobial  effect  and  to  be  non-
toxic to mammalian cells (less than 350 mcg/day 
allowed by Environmental Protection Agency as a 
maximum daily reference).
In the present study the synthesis of silver NPs by 
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Zeta  Sizer  Malvern  Nano-ZS.  Size  distribution 
of the particles was estimated using  LPA images 
by  measurement  of  diameters  of  at  least  50 
nanoparticles. SEM images were taken by “Zeiss-
DSM 940 A” instrument. 
Anti-bacterial determination 
The antimicrobial activities of the NPs suspension 
were determined by measurement of their minimum 
inhibitory concentrations (MICs) using the standard 
micro dilution method (10). The bacterial strains used 
in  this  study  were  Staphylococcus  aureus  (ATCC 
6538), Staphylococcus epidermidis (ATCC 12228), 
Escherichia  coli  (ATCC  8739)  and  Pseudomonas 
aeruginosa (ATCC 9027) which were provided by 
the Department of Drug and Food Control, Faculty of 
Pharmacy, Tehran University of Medical Sciences. 
Two-fold dilutions of silver NPs solutions and silver 
nitrate solution were prepared in Muller-Hinton broth 
in the concentration range of 2-512 ppm equivalent 
to pure silver content (11).
Bacterial death rate determination 
The  kinetics  of  death  rates  of  the  synthesized 
nanosilver  particles  as  well  as  silver  nitrate  were 
determined by incubation of 107-108 CFU/ml of the 
individual bacteria in Muller-Hinton broth tubes.
RESULTS  AND DISCUSSION
Physical characterization of the particles
The SEM images of two types of silver NPs depicted 
in Figures 1 and 2  illustrates an uncontrolled growth 
of  metallic  particles  in  EG  silver  NPs.  Figure  2 
shows a SEM image of synthesised silver NPs by 
glucose  which  are  spherical  in  shape  and  have  a 
smooth surface morphology. It is also apparent that 
resulting  NPs  are  more  and  less  uniform  in  size 
and  shape.  The  UV-Vis  spectrum  of  the  EG  and 
synthesized NPs by glucose and also that of silver 
nitrate is illustrated in figure 3.  Absorption between 
400 – 450 nm is usually characteristic of silver NPs 
in the UV-Vis region (12). Figures 4 and 5 show size 
distributions of nanoparticles in two colloids which 
were  determined  by  laser  particle  analyzer  (Zeta 
Sizer Malvern Nano-ZS). While most of them were 
chemical  reduction  method  using  ethylene  glycol 
and glucose as the reducing agents is described. Size 
distribution and antimicrobial activity of the silver 
nanocolloids are also compared.  
MATERIAL AND METHODS
Materials
Silver  nitrate  (purity > 99%,  Aldrich)  was  used 
as  precursor  in  the  preparation  of  silver  NPs. 
Glucose  and  poly  (N-vinylpyrrolidon)  (PVP  k30) 
were purchased from Merck. Ethylene glycol was 
purchased from Fisher (99.9 %, HPLC grade). 
Preparation of silver NPs
Two colloidal forms of silver NPs were prepared 
by one-step synthetic method using ethylene glycol 
and  glucose  as  reducing  agents.  Uniform  silver 
nanoparticles were obtained by reduction of silver 
nitrate  at  50°-70°C  under  atmospheric  pressure. 
Poly vinyl pyrrolidone (PVP) was used as stabilizer.   
Ethylene  glycol  silver  NPs  were  synthesized  by 
dissolving AgNO3 (157 mg) and PVP (5g) in 100 ml 
of 99.9% ethylene glycol (9).  For the preparation of 
glucose silver NPs, AgNO3 (157 mg) and PVP (5g) 
were dissolved in 100 ml of 40% (w/w) of glucose 
syrup. In order to be confident that the reaction is 
complete and all the ionic silver have been converted 
to nanoparticles, 5ml of sodium chloride was added 
to the samples.  Creation of turbidity in the reaction 
solution indicates the presence of ionic silver while a 
clear solution confirms completion of the reaction.
Gravimetric method was utilized to measure the total 
nanosilver content of solutions. Nano silver particles 
were dissolved in 10% nitric oxide. Subsequently, 
sodium  chloride  (in  excess)  was  added  to  the 
solution. The total amount of silver was determined 
by weighing the precipitated AgCl.     
Characterization techniques
Size,  morphology  and  composition  of  NPs  were 
studied  by  scanning  electron  microscopy  (SEM), 
laser particle analyzer (LPA) and ultraviolet-visible 
spectroscopy  (UV-Vis).  UV-Vis  spectroscopy  was 
performed using a Cecil CE 9200 super Aquarius 
Spectrophotometer.  LPA  was  performed  using  a 
Table1. Minimum inhibitory and minimum bactericidal concentrations (MIC and MBC) of ethylene glycol and glucose silver colloids 
against some Gram positive and Gram negative bacteria compared with ionic silver.
*The figures quoted are means of at least three determinations.
MIC/MBC* (µg/ml)
E. coli P. aeruginosa S. epidermidis S. aureus
Silver ion 11/12 9/12 15/22 18/20
EG silver NPs  10.5/20 7.5/12.5 10/16 20/20
Glucose silver NPs  19/21 22/36 20/28 28/28
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Figure 1. SEM image of silver nanoparticles in ethylene glycol silver colloid. Silver particles 
prepared from 1mM AgNO3 solution. 
Figure 1. SEM image of silver nanoparticles in ethylene glycol 
silver colloid. Silver particles prepared from 1mM AgNO3 solution.
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Figure 2. SEM image of silver nanoparticles in glucose silver colloid. Silver particles were from 
1mM AgNO3 solution. 
Figure 2. SEM image of silver nanoparticles in glucose silver 
colloid. Silver particles were from 1mM AgNO3 solution.
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Figure 3. UV–Vis absorption spectrum of silver nanoparticles in ethylene glycol colloid (1), glucose 
colloid (2) and silver nitrate. 
Figure 3. UV–Vis absorption spectrum of silver nanoparticles in 
ethylene glycol colloid (1), glucose colloid (2) and silver nitrate.
around  10-100  nm,  smaller  particles  (8nm)  were 
produced in glucose colloid rather than EG (15nm).
Anti-bacterial activity
Table 1 shows the MICs and MBCs of silver NPs 
and  silver  nitrate  against  the  individual  tested 
bacterial strains. These results tend to indicate that 
the EG silver NPs had higher anti-bacterial activity 
than glucose silver NPs. 
The kinetics of death rate of different bacteria in 
solutions containing synthesized NPs by glucose and 
EG as well as silver nitrate are shown in figures 6-9. 
After 10 min the viable cells of S. aureus in glucose 
synthesized silver NPs solution showed 2 logs more 
than other solutions while the reduction rate for S. 
epidermidis was similar in all solutions. E. coli was 
the most sensitive to all silver compounds and the 
microbial  count  dropped  to  less  than  10  CFU/ml 
after just one min. On the other hand P. aeruginosa 
was resistance to silver ions and glucose silver NPs.
Synthesis  of  silver  nanoparticles  by  chemical 
reduction is considered a cheap and simple method. 
In the current study poly vinyl pyrolidone (PVP) 
was  used  as  a  stabilizer  of  the  silver  NPs.  PVP 
could also control the reduction rate of silver ions 
as  well  as  aggregation  of  metal  atoms  (13).  The 
reducing agent showed to have an important impact 
on the uniformity of the nanoparticles. The silver 
nanoparticles  produced  by  using  glucose  as  the 
reducing  agent  compared  to  those  produced  by 
ethylene glycol showed better uniformity. 
The optical absorption spectra of metal nanoparticles 
are  dominated  by  Surface  Plasmon  Resonances   
(SPR),  which  shift  to  longer  wavelengths  by 
increasing  the particle size (14). Also small spherical 
NPs (<20nm) exhibit a single surface plasmon band 
(15) which is consistent with the results depicted in 
figure 3.
 As shown in figure 3 the PVP-stabilized silver NPs 
solution, exhibited the surface plasmon resonance 
absorption  band  at  405  to  410 nm  for  glucose 
and EG colloids. The stability of silver NPs were 
monitored for 3 months which showed a SPR peak 
at the same wavelength. If nanoparticles in polymer 
have a narrow size distribution, the peak shape is 
symmetrical and the value of the full width at half-
maximum (FWHM) is small (16). The silver colloids 
exhibited symmetric band and narrow FWHM for 
both  colloids.  Size  distribution  of  the  silver  NPs 
were almost uniform and well dispersed (17).
The  MICs  of  silver  reported  by  Cho  et.  al  were 
7.5µg/ml and 12.5 µg /ml for P. aeruginosa and S. 
aureus, respectively (18). Although the MICs of the 
current study against P. aeruginosa was close to the 
reported  values.  but  those  obtained  for  S.  aureus 
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Figure 4. Particle size distribution of glucose nanosilver colloid 
using laser particle analyzer (Zeta Sizer Malvern Nano-ZS). 
Figure 5. Particle size distribution of ethylene glycol nanosilver 
colloid using laser particle analyzer (Zeta Sizer Malvern Nano-ZS).
Figure 6. The kinetics of death rate of S. aureus in presence of 
ethylene glycol and glucose silver nanoparticles compared to silver 
nitrate.
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Figure 4. Particle size distribution of glucose nanosilver colloid using laser particle analyzer (Zeta 
Sizer Malvern Nano_ZS)  
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Figure 5. Particle size distribution of ethylene glycol nanosilver colloid using laser particle analyzer
(Zeta Sizer Malvern Nano_ZS) 
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Figure 4. Particle size distribution of glucose nanosilver colloid using laser particle analyzer (Zeta 
Sizer Malvern Nano_ZS)  
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Figure 5. Particle size distribution of ethylene glycol nanosilver colloid using laser particle analyzer
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Figure 6. The kinetics of death rate of S. aureus in presence of ethylene glycol and glucose silver 
nanoparticles compared to silver nitrate.  
Figure 7. The kinetics of death rate of S. epidermidis in the presence of ethylene glycol and glucose 
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Figure 7. The kinetics of death rate of S. aureus, S. epidermidis, 
P. aeruginosa and E. coli in the presence of ethylene glycol and 
glucose silver nanoparticles compared to silver nitrate
Figure 8. The kinetics of death rate of P. aeruginosa in the presence 
of ethylene glycol and glucose silver nanoparticles compared to silver 
nitrate. 
Figure 9. The kinetics of death rate of E. coli in the presence of 
ethylene glycol and glucose silver nanoparticles compared to silver 
nitrate. 
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Figure 6. The kinetics of death rate of S. aureus in presence of ethylene glycol and glucose silver 
nanoparticles compared to silver nitrate.  
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silver nanoparticles compared to silver nitrate.  
Figure 8. The kinetics of death rate of P. aeruginosa in the presence of ethylene glycol and glucose 
silver nanoparticles compared to silver nitrate.  
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Figure 9. The kinetics of death rate of E. coli in the presence of ethylene glycol and glucose silver 
nanoparticles compared to silver nitrate.  
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were far beyond. Feng et.al, (19) reported an MIC of 
14.1 mg of silver for E. coli which is in accordance 
with our results.
Figure 8 indicates that both NPs could present their 
bactericidal effects in less than 15 minutes against 
P.  aeruginosa  while  Iroha  et.al  have  recently 
shown that the colloidal silver could eradicate the 
same bacteria not less than 90 min (20). Glucose 
silver NPs showed better anti bactericidal effect on 
the tested bacteria in comparison to the EG particles.   
This could probably be due to the size distribution 
of particles in glucose which were smaller than the 
EG colloids. 
The results of the present study suggest that silver 
NPs  which  were  prepared  using  glucose  as  the 
reducing agent had a better particle uniformity and 
as a result superior anti-bacterial action compared 
to  the  nanosilver  particles  synthesized  by  using 
ethylene  glycol.  Although  silver  ions  such  as 
AgNO3  have  a  somewhat  better  antimicrobial 
effect but they are unstable in the presence of light 
or other radiation. Glucose nanosilver colloids are 172
biologically compatible and have the potential to be 
used in medical and pharmaceutical applications due 
to their homologous size distribution and superior 
antimicrobial actions. 
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